
Nikhil Baheti
About Nikhil Baheti
Data last updated:
Nikhil Baheti is a Designated Partner at Dohiyi Enterprises Llp (since 2023), Designated Partner at Descanso Enterprises Llp (since 2023) and Designated Partner at Aequanimus Enterprises Llp (since 2023), and holds 10 more current directorships. The companies operate in Real Estate and Construction, Pharma and Chemicals and Materials. Earlier, Nikhil Baheti was a Director at Brs Global Innovation Center Private Limited (2020–2023) and Director at Laxai Life Sciences Private Limited (2017–2019) and 6 more.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Designated Partner | 25 Oct 2023 | 2023 | Active | ||
| Designated Partner | 25 Oct 2023 | 2023 | Active | ||
| Designated Partner | 06 Sep 2023 | 2023 | Active | ||
| Designated Partner | 06 Sep 2023 | 2023 | Active | ||
| Designated Partner | 06 Sep 2023 | 2023 | Active | ||
| Designated Partner | 06 Sep 2023 | 2023 | Active | ||
| Designated Partner | 06 Sep 2023 | 2023 | Active | ||
| Designated Partner | 05 Sep 2023 | 2023 | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Dec 2020 | 2019 | Strike Off | ||
| Director | 13 Apr 2017 | 2006 | ₹178 Cr (FY 2024) | Active | |
| Director | 09 Sep 2021 | 2012 | ₹1.58 Cr (FY 2021) | Active | |
| Director | 04 Mar 2020 | 2017 | ₹149 Cr (FY 2021) | Active | |
| Additional Director | 07 Nov 2020 | 2019 | Strike Off | ||
| Director | 08 Jul 2015 | 2015 | ₹44,165 (FY 2022) | Active | |
| Designated Partner | 28 Nov 2020 | 2020 | Strike Off | ||
| Director | 18 Jan 2022 | 2022 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Nikhil Baheti
| Name | DIN | Company | Designation |
|---|---|---|---|
| Sourabh Gupta | 08258046 | Dohiyi Enterprises Llp , Descanso Enterprises Llp and 2 more | Designated Partner |
| Akash Baheti | 10301896 | Aequanimus Enterprises Llp , Datti Enterprises Llp | Designated Partner |
| Trupty Athasniya | 09430217 | Hacana Enterprises Llp , Prosperidad Enterprises Llp and 2 more | Designated Partner |
| Unnathi Ladda | 10301895 | Ademaro Enterprises Llp , Vrede Enterprises Llp | Designated Partner |
| Radheshyam Kabra | 09101885 | Elegant Elite Invesco Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nikhil Baheti
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nikhil Baheti
Nikhil Baheti currently holds 13 directorships: Dohiyi Enterprises Llp (Designated Partner, since 25 Oct 2023); Descanso Enterprises Llp (Designated Partner, since 25 Oct 2023); Aequanimus Enterprises Llp (Designated Partner, since 06 Sep 2023); Hacana Enterprises Llp (Designated Partner, since 06 Sep 2023); Prosperidad Enterprises Llp (Designated Partner, since 06 Sep 2023); and 8 more.
Nikhil Baheti was first appointed on 08 Jul 2015 as Director at Laxai Biopharma Private Limited. The most recent appointment on record is 25 Oct 2023 at Descanso Enterprises Llp.
Nikhil Baheti held 8 earlier board appointments: Brs Global Innovation Center Private Limited (Director, 01 Dec 2020 to 13 Jan 2023); Laxai Life Sciences Private Limited (Director, 13 Apr 2017 to 01 Oct 2019); Epione Labs Private Limited (Director, 09 Sep 2021 to 30 May 2022); Therapiva Private Limited (Director, 04 Mar 2020 to 27 Sep 2021); Therapiva (Vizag) Private Limited (Additional Director, 07 Nov 2020 to 09 Jun 2022); and 3 more.
The current boards of Nikhil Baheti's companies include Sourabh Gupta (Dohiyi Enterprises Llp), Akash Baheti (Aequanimus Enterprises Llp), Trupty Athasniya (Hacana Enterprises Llp), Unnathi Ladda (Ademaro Enterprises Llp), Radheshyam Kabra (Elegant Elite Invesco Llp).